Form 8-K - Current report:
SEC Accession No. 0001213900-19-000223
Filing Date
2019-01-04
Accepted
2019-01-04 17:10:25
Documents
1
Period of Report
2019-01-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k010119_relmadatherap.htm 8-K 15525
  Complete submission text file 0001213900-19-000223.txt   16734
Mailing Address 750 THIRD AVENUE, 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE, 9TH FLOOR NEW YORK NY 10017 212-547-9591
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-55347 | Film No.: 19511034
SIC: 2834 Pharmaceutical Preparations